| # | Drug | Count |
|---|---|---|
| 0 | ATAZANAVIR | 3 |
| 1 | ATAZANAVIR AND COBICISTAT | 3 |
| 2 | RITONAVIR | 3 |
| 3 | RITONAVIR 100 MG | 3 |
| 4 | ABACAVIR AND LAMIVUDINE | 2 |
| 5 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 |
| 6 | ERYTHROMYCIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATAZANAVIR AND COBICISTAT | 3 | 0.0122 |
| 1 | ABACAVIR AND LAMIVUDINE | 2 | 0.0100 |
| 2 | ATAZANAVIR | 3 | 0.0002 |
| 3 | RITONAVIR 100 MG | 3 | 0.0002 |
| 4 | ERYTHROMYCIN | 1 | 0.0001 |
| 5 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytochrome P450 3A Inhibitor [EPC] | 6 | 0.0001 |
| 1 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |